Dynavax Technologies reported $105.9M in Trade Debtors for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Adma Biologics ADMA:US $ 23.54M 8.18M
Agenus AGEN:US $ 1.44M 0.74M
Alexion Pharmaceuticals ALXN:US $ 1473M 63.7M
Amgen AMGN:US $ 4479M 56M
AstraZeneca AZN:LN 6.84B 214M
Astrazeneca AZN:US 6.84B 214M
Biogen BIIB:US $ 2110.2M 113.9M
Biomarin Pharmaceutical BMRN:US $ 424.42M 28.32M
BioSpecifics Technologies BSTC:US 13.59M 1.9M
Bristol Myers Squibb BMY:US $ 11275M 2615M
Chimerix CMRX:US 36K 446K
Dynavax Technologies DVAX:US $ 105.9M 21.91M
Gilead Sciences GILD:US $ 4149M 224M
Glaxosmithkline GSK:US $ 7507M 324M
Gw Pharmaceuticals GWPH:US $ 84.95M 13.78M
Nektar Therapeutics NKTR:US $ 28.87M 0.28M
Neurocrine Biosciences NBIX:US $ 158.5M 10.7M
Novartis NOVN:VX 8.65B 173M
Regeneron Pharmaceuticals REGN:US $ 6998.6M 2825.6M
Sarepta Therapeutics SRPT:US $ 148.26M 11.9M
Vertex Pharmaceuticals VRTX:US $ 929.14M 48.41M